Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

(2015) Dirk Schadendorf et al.   JOURNAL OF CLINICAL ONCOLOGY

Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma

(2014) Evan J. Lipson et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients

(2013) Carlos Benítez et al.   HEPATOLOGY

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

(2013) Rocío García de la Garza et al.   LIVER TRANSPLANTATION

Malignant Melanoma in Solid Transplant Recipients

(2011) Jerry D. Brewer   ARCHIVES OF DERMATOLOGY

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs

(2010) Alberto Sánchez–Fueyo et al.   GASTROENTEROLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review

(2009) P. Dillon et al.   MEDICAL ONCOLOGY